title: Patient-reported outcomes after neoadjuvant therapy for rectal cancer: a systematic review.
abstract: Neoadjuvant therapy followed by total mesorectal excision is standard of care for locally advanced rectal cancer. However, this approach has been previously shown to be associated with high rate of morbidity and it may have a negative effect on patients' reported outcomes (PROs). In order to summarize findings on the effect of the neoadjuvant approach on PROs, we systematically reviewed articles published in the last five years. Thirty-five articles met the inclusion criteria. Ten articles compared the effect of surgery with and without neoadjuvant therapy, six articles compared different neoadjuvant therapies, ten articles reported on patients who were all treated with neoadjuvant therapy, and nine articles examined the effect of neoadjuvant therapy in the analyses. The results are summarized by function investigated and critically commented.
authors.affiliation: Clinica Chirurgica I, Policlinico Universitario, via Giustiniani, 2, 35128 Padova, Italy.
authors.forename: Teresa
authors.initials: T
authors.lastname: Gavaruzzi
authors.forename: Lorella
authors.initials: L
authors.lastname: Lotto
authors.forename: Francesca
authors.initials: F
authors.lastname: Giandomenico
authors.forename: Alessandro
authors.initials: A
authors.lastname: Perin
authors.forename: Salvatore
authors.initials: S
authors.lastname: Pucciarelli
mesh_terms: D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D063868:Patient Outcome Assessment; D012004:Rectal Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
keywords: bowel function; chemoradiotherapy; fecal continence; neoadjuvant therapy; patient-reported outcomes; quality of life; radiotherapy; rectal cancer; sexual function; urinary function